Invo Bioscience Stock Alpha and Beta Analysis
| INVO Stock | USD 1.01 0.10 10.99% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as INVO Bioscience. It also helps investors analyze the systematic and unsystematic risks associated with investing in INVO Bioscience over a specified time horizon. Remember, high INVO Bioscience's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to INVO Bioscience's market risk premium analysis include:
Beta 1.54 | Alpha 1.03 | Risk 18.86 | Sharpe Ratio 0.0657 | Expected Return 1.24 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
INVO |
INVO Bioscience Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. INVO Bioscience market risk premium is the additional return an investor will receive from holding INVO Bioscience long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in INVO Bioscience. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate INVO Bioscience's performance over market.| α | 1.03 | β | 1.54 |
INVO Bioscience expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of INVO Bioscience's Buy-and-hold return. Our buy-and-hold chart shows how INVO Bioscience performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.INVO Bioscience Market Price Analysis
Market price analysis indicators help investors to evaluate how INVO Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading INVO Bioscience shares will generate the highest return on investment. By understating and applying INVO Bioscience stock market price indicators, traders can identify INVO Bioscience position entry and exit signals to maximize returns.
INVO Bioscience Return and Market Media
The median price of INVO Bioscience for the period between Mon, Feb 12, 2024 and Sun, May 12, 2024 is 1.01 with a coefficient of variation of 17.46. The daily time series for the period is distributed with a sample standard deviation of 0.18, arithmetic mean of 1.03, and mean deviation of 0.13. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Ryan Barbara of 10435 shares of INVO Bioscience subject to Rule 16b-3 | 03/01/2024 |
2 | Should You Hold Invo Bioscience Inc Stock Wednesday - InvestorsObserver | 03/20/2024 |
3 | INVO Bioscience Stock Price Down 8.8 percent - Defense World | 03/26/2024 |
4 | Why Is Trilogy Metals Stock Down 29 percent Today | 04/17/2024 |
5 | Insider Trading | 04/18/2024 |
6 | INVO Bioscience Shares Down 7 percent - Defense World | 05/07/2024 |
About INVO Bioscience Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including INVO or other stocks. Alpha measures the amount that position in INVO Bioscience has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 0.33 | 0.25 | 0.83 | 0.87 | Days Of Inventory On Hand | 724.13 | 290.22 | 49.91 | 47.41 |
INVO Bioscience Upcoming Company Events
As portrayed in its financial statements, the presentation of INVO Bioscience's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, INVO Bioscience's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of INVO Bioscience's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of INVO Bioscience. Please utilize our Beneish M Score to check the likelihood of INVO Bioscience's management manipulating its earnings.
| 15th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with INVO Bioscience
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out INVO Bioscience Backtesting, INVO Bioscience Valuation, INVO Bioscience Correlation, INVO Bioscience Hype Analysis, INVO Bioscience Volatility, INVO Bioscience History and analyze INVO Bioscience Performance. To learn how to invest in INVO Stock, please use our How to Invest in INVO Bioscience guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for INVO Stock analysis
When running INVO Bioscience's price analysis, check to measure INVO Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INVO Bioscience is operating at the current time. Most of INVO Bioscience's value examination focuses on studying past and present price action to predict the probability of INVO Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INVO Bioscience's price. Additionally, you may evaluate how the addition of INVO Bioscience to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
INVO Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.